Skip to content
Review Open access

A multi-layer framework for computational cancer epigenomics

Aug 2026 · Academia Molecular Biology and Genomics · 0 citations · 126 references

TL;DR

A structured multi-layer interpretation framework is proposed that links computational outputs across data-level processing, epigenomics-informed integrative regulatory modeling, and multi-omics-informed clinical interpretation, enabling traceable and mechanistically interpretable clinical inference.

Abstract

Cancer epigenomics has become central to understanding tumor initiation, progression, heterogeneity, and therapeutic response. High-throughput profiling technologies including bisulfite sequencing, chromatin immunoprecipitation sequencing (ChIP-seq), assay for transposase-accessible chromatin using sequencing (ATAC-seq), and RNA sequencing (RNA-seq) generate complex, multi-dimensional datasets that require robust computational frameworks for meaningful interpretation. This review outlines key bioinformatics workflows in cancer epigenomics, including data preprocessing, quality control, sequence alignment, signal detection, and differential analysis. While epigenomic data provide a mechanistic regulatory foundation, their full interpretive value emerges through integration with genomic, transcriptomic, and clinical data within computational oncology frameworks. Accordingly, we emphasize integrative modeling approaches that combine multi-omics data to uncover regulatory mechanisms, identify biomarkers, and define disease-associated molecular subtypes. Machine learning methods are increasingly applied for classification, prognosis prediction, and therapeutic response modeling; however, challenges remain in model interpretability, reproducibility, and external validation. We further highlight critical analytical limitations, including data heterogeneity, tumor complexity, lack of standardized workflows, and the persistent gap between association and biological mechanism. Emerging advances in single-cell epigenomics, spatial profiling, and explainable AI offer new opportunities to refine biological insight and clinical translation. Importantly, we propose a structured multi-layer interpretation framework that links computational outputs across data-level processing, epigenomics-informed integrative regulatory modeling, and multi-omics-informed clinical interpretation. This framework differs from existing pipelines by explicitly constraining how information is transformed across analytical layers, enabling traceable and mechanistically interpretable clinical inference.

Read PDF

Similar papers

Review Open access Feb 2026

Transcriptomic and epigenomic insights into ovarian cancer: a bioinformatics perspective – a narrative review

Ovarian cancer is a highly heterogeneous malignancy with complex molecular underpinnings that extend beyond genomic mutations to encompass transcriptomic and epigenomic alterations. Advances in next-generation sequencing and bioinformatics have enabled comprehensive profiling of gene expression patterns, non-coding RNA...

E. I. Obeagu · 0 citations
Review Aug 2026

Artificial Intelligence-Driven Multiomics Integration in Lung Cancer: From Data Convergence to Precision Phenomics.

Precision phenomics is introduced as a unifying framework that links molecular, spatial, functional, and clinical characteristics of tumors to support personalized cancer management and has the potential to transform lung cancer research and improve patient outcomes.

Sanjukta Dasgupta, D. De · 0 citations
Review Open access Aug 2026

Integrative Epigenomics: Bioinformatics Strategies for Multi-Omics Data Analysis in Health and Disease

Background: Epigenomics has emerged as an essential field in modern molecular biology, providing a critical layer of gene regulation. DNA methylation, histone modifications and alterations to the chromatin accessibility of DNA have been widely associated with complex diseases including cancer. The most recent developme...

Shikhi Baruri, Lalit Batra, Sohome Adhikari et al. · 0 citations
Open access Aug 2026

Integrative analysis of bulk, single-cell, and spatial transcriptomes reveals a clinically relevant transcriptional program from hepatocellular carcinoma to pan-cancer

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, underscoring the urgent need for robust molecular signatures that support multiple clinical tasks and generalize across diverse transcriptomic platforms. We performed an integrative analysis of 1,300 HCC transcrip...

Tho Ngoc-Quynh Le, Nhi Doan Yen Nguyen, Thanh Nguyen et al. · 0 citations
Review Aug 2026

AI-Driven Multiomics Biomarkers for Precision Oncology: Navigating the Translational Gap and Regulatory Hurdles.

This review critically evaluates how advanced technologies operating in an integrated manner facilitate precision oncology by supporting fields such as genomics, transcriptomics, proteomics, metabolomics, and radiomics and provides an integrative roadmap for modern, multiomics-driven biomarker approaches in precision o...

Ujwal Havelikar, Atharva A. Shinde, Hrushikesh Mhaismale et al. · 0 citations
Review Open access Sep 2026

Machine learning approaches for cancer prognosis and diagnosis via non-coding RNA: a comprehensive review

Abstract Non-coding RNAs (ncRNAs), once considered genomic dark matter, are now established as key regulators of gene expression with widespread roles in cellular homeostasis and disease. In cancer, ncRNA expression is frequently and systematically dysregulated, and many of these molecules circulate in stable, protecte...

Md Shafayet Hossain, Yi-Ping Phoebe Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.